Proceedings of the National Academy of Sciences · 2011 · 267 citations · 29 references
Life SciencesInfectious DiseasesMolecular BiologyImmunizationMolecular VirologyVirologyAntibody-antigen RecognitionVaccinationViral GeneticsViral VaccinesAntibodiesAntigenic Variation In VirusesPoint Mutation EffectsPolyclonal AntibodiesViral Antigenic DriftViral Antigenic ShiftViral Envelope GlycoproteinsViral Glycoproteins
Seasonal epidemics caused by influenza virus are driven by antigenic changes (drift) in viral surface glycoproteins that allow evasion from preexisting humoral immunity. Antigenic drift is a feature of not only the hemagglutinin (HA), but also of neuraminidase (NA). We have evaluated the antigenic evolution of each protein in H1N1 and H3N2 viruses used in vaccine formulations during the last 15 y by analysis of HA and NA inhibition titers and antigenic cartography. As previously shown for HA, genetic changes in NA did not always lead to an antigenic change. The noncontinuous pattern of NA drift did not correspond closely with HA drift in either subtype. Although NA drift was demonstrated using ferret sera, we show that these changes also impact recognition by NA-inhibiting antibodies in human sera. Remarkably, a single point mutation in the NA of A/Brisbane/59/2007 was primarily responsible for the lack of inhibition by polyclonal antibodies specific for earlier strains. These data underscore the importance of NA inhibition testing to define antigenic drift when there are sequence changes in NA.
29
Mapping the Antigenic and Genetic Evolution of Influenza Virus
Derek J. Smith, Alan S. Lapedes, J.C. de Jong et al. · Science · 2004 · 2K citations
Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults
Carolyn B. Bridges, W. Thompson, Martin I. Meltzer et al. · JAMA · 2000 · 660 citations